Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Nakanishi A"'
Autor:
Akiko Fujii, Shinya Sakata, Keita Nakatomi, Yoichi Nakanishi, Ryo Toyozawa, Koji Inoue, Noriko Hidaka, Kazuko Sakai, Isamu Okamoto, Keiichi Ota, Junji Kishimoto, Taishi Harada, Eiji Iwama, Kazuto Nishio, Junko Hisasue, Takayuki Shimose, Koichi Azuma, Noriaki Nakagaki
Publikováno v:
Cancer. 126:219-227
BACKGROUND The aim of this study was to evaluate the potential of liquid biopsy for prediction of the efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment and for assessment of the changes in genetic alteratio
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yoichi Nakanishi, Tomonori Hirashima, Masayuki Takeda, Haruko Daga, Takashi Seto, Hidetoshi Hayashi, Shunichi Sugawara, Isamu Okamoto, Toshiyuki Sawa, Naoyuki Nogami, Morihito Okada, Kazuhiko Nakagawa, Haruhiro Saito, Koichi Azuma, Takeharu Yamanaka, Akihito Kubo, Kimio Yonesaka, Yoshiko Urata, Eiji Miyahara, Haruyasu Murakami
Publikováno v:
Cancer. 122(7)
BACKGROUND Bevacizumab combined with platinum-based chemotherapy has been established as a standard treatment option in the first-line setting for advanced nonsquamous non–small cell lung cancer (NSCLC). However, there has been no evidence to suppo
Autor:
M T Hiroji Ishida, Takashi Koshikawa, Emiko Takahashi, Shigeo Nakamura, Yasushi Yatabe, Hayao Nakanishi, C T Yuji Ueyama, C T Masako Kobayashi
Publikováno v:
Cancer. 108:114-118
BACKGROUND Although ascites cytology is important for therapeutic strategies, it is difficult to distinguish cancer infiltration from reactive mesothelial proliferation in some patients. In this study, the authors applied CDX2 immunocytochemistry to
Autor:
Kazuhiko Nakagawa, Hisao Uejima, Tatsuhiko Kashii, Minoru Takada, Kaoru Matsui, Y. Takada, Nobuyuki Yamamoto, Yoichi Nakanishi, Takahiko Sugiura, Terufumi Kato, Shun Ichi Negoro, Masahiro Fukuoka
Publikováno v:
Cancer. 107:599-605
BACKGROUND. Combined gemcitabine and carboplatin (GC) and combined gemcitabine and vinorelbine (GV) are active and well tolerated chemotherapeutic regimens for patients with advanced nonsmall cell lung cancer (NSCLC). The authors conducted a randomiz
Autor:
Dong Ik Lee, Douglas D. Ross, Arif Hussain, John P. O'Neill, Stephen J. Meltzer, Bin Zhang, Florin M. Selaru, Chidambaram Natesa Velalar, Takeo Nakanishi, Yao Tang
Publikováno v:
Cancer. 107:649-659
BACKGROUND. Thapsigargin (TG) is a potent inhibitor of sarcoplasmic/endoplasmic reticulum Ca2+ ATPases (SERCAs). TG-based prodrugs are being developed for the treatment of prostate cancer (PC). To develop optimal TG-based therapeutics it is important
Publikováno v:
Cancer. 103:307-312
BACKGROUND Patients with hepatocellular carcinoma (HCC) who showed early massive disease recurrence due to hematogenous intrahepatic metastasis after curative resection had a poor prognosis. The authors previously reported that Akt phosphorylation wa
Autor:
Setsuo Hirohashi, Yuko Sasajima, Yukihiro Nakanishi, Katsumi Hanada, Naoya Yamazaki, Aya Nishizawa, Kimio Yoshimura, Yae Kanai, Akifumi Yamamoto
Publikováno v:
Cancer. 103:1693-1700
BACKGROUND The E-cadherin–mediated cell adhesion system is frequently inactivated by multiple mechanisms and is involved in tumor progression in many types of cancer. Recently, the authors reported a novel cell membrane glycoprotein, dysadherin, wh
Autor:
Yong Nan Li, Tsuneharu Miki, Hiroyuki Nakanishi, Osamu Yoshida, Yoichi Mizutani, Masakazu Fukushima, Hiromi Wada
Publikováno v:
Cancer. 100:723-731
BACKGROUND 5-Fluorouracil (5-FU), an antitumor agent, is used clinically against a variety of malignancies, including bladder carcinoma. 5-FU is a prodrug, and orotate phosphoribosyltransferase (OPRT) is the principal enzyme that converts 5-FU direct